Pillyze, a Nutrition Management Platform, Raises $9 Million in Funding to Lead the Digital Transformation of the Healthcare Market

Pillyze, the hyper-personalized nutrition management platform, has closed a $9 million (KRW 12 billion) Series A funding round. This brings Pillyze’s total funding to $11.2 million (KRW 15 billion).

The round was led by Capstone Partners. New investors include Samsung Next, the corporate venture capital (CVC) arm of Samsung Electronics, KB Investment and KDB, with follow-on participation from seed investors Strong Investments, Primer and Nextrans. With the Series A funding, Pillyze will focus on accelerating its digital transformation business in the healthcare market and deepening its expertise in platform services.

In addition, Pillyze plans to build Pillyze into a national healthcare platform by enhancing its expertise in hyper-personalized health analytics, such as body composition analysis and genetic testing based on hyper-personalized AI technology and expanding Pillyze’s team of healthcare experts.

Pillyze is a hyper-personalized nutrition and diet management platform company founded in 2021. Its key services include nutrient combination analysis, expert advice from pharmacists and nutritionists, diet management features, Today’s Diet Score that integrates meal and nutrient scores, hydration feedback, and exercise management features.

Pillyze is a healthcare super-app that can integrally analyze, recommend and manage nutrients, diet and exercise based on Personal Health Record (PHR) data such as medical exam records. In less than a year since its launch, it has become the #1 platform for ultra-personalized nutrition and diet management.

It quickly gained traction with users for its intuitive graphics, ease of use, and analytics and feedback services. Within 14 months of launch, it reached 750,000 monthly active users and accumulated 850,000 nutrient combination analyses.

“The Pillyze team is a serial entrepreneur with experience building category #1 platforms,” said Eunkang Song, CEO of Capstone Partners, which led the investment. “They have the experience and know-how to efficiently build mega-platforms, and we believe they have the potential to create a super-platform in the healthcare market.”

“The growing interest in health after COVID-19 and the rapid development of various wearable device technologies and artificial intelligence (AI) technologies are creating a market environment for the emergence of super-platforms in healthcare,” said Insik Shin, CEO of Pillyze. “With our portfolio of hyper-personalized services and expertise, Pillyze plans to present a new paradigm to lead the digital transformation of the healthcare market.”